Standard
The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer. / Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; Larsson, Berit; Connor, Jason T.; Gabriel, Erin E.; Thellenberg, Camilla; Janes, Elin; Enblad, Gunilla; Ullen, Anders; Hjalm-Eriksson, Marie; Oldenburg, Jan; Ost, Piet; Lindberg, Johan; Eklund, Martin; Gronberg, Henrik.
I:
Trials, Bind 21, 579, 2020.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Crippa, A, De Laere, B, Discacciati, A, Larsson, B, Connor, JT
, Gabriel, EE, Thellenberg, C, Janes, E, Enblad, G, Ullen, A, Hjalm-Eriksson, M, Oldenburg, J, Ost, P, Lindberg, J, Eklund, M & Gronberg, H 2020, '
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer',
Trials, bind 21, 579.
https://doi.org/10.1186/s13063-020-04515-8APA
Crippa, A., De Laere, B., Discacciati, A., Larsson, B., Connor, J. T.
, Gabriel, E. E., Thellenberg, C., Janes, E., Enblad, G., Ullen, A., Hjalm-Eriksson, M., Oldenburg, J., Ost, P., Lindberg, J., Eklund, M., & Gronberg, H. (2020).
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer.
Trials,
21, [579].
https://doi.org/10.1186/s13063-020-04515-8Vancouver
Crippa A, De Laere B, Discacciati A, Larsson B, Connor JT
, Gabriel EE o.a.
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer.
Trials. 2020;21. 579.
https://doi.org/10.1186/s13063-020-04515-8Author
Crippa, Alessio ; De Laere, Bram ; Discacciati, Andrea ; Larsson, Berit ; Connor, Jason T. ; Gabriel, Erin E. ; Thellenberg, Camilla ; Janes, Elin ; Enblad, Gunilla ; Ullen, Anders ; Hjalm-Eriksson, Marie ; Oldenburg, Jan ; Ost, Piet ; Lindberg, Johan ; Eklund, Martin ; Gronberg, Henrik. / The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer. I: Trials. 2020 ; Bind 21.
Bibtex
@article{25f1352419be459e8a7564fcccca3e1b,
title = "The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer",
keywords = "Clinical trial platform, Genetic biomarker, Prostate cancer, Precision medicine",
author = "Alessio Crippa and {De Laere}, Bram and Andrea Discacciati and Berit Larsson and Connor, {Jason T.} and Gabriel, {Erin E.} and Camilla Thellenberg and Elin Janes and Gunilla Enblad and Anders Ullen and Marie Hjalm-Eriksson and Jan Oldenburg and Piet Ost and Johan Lindberg and Martin Eklund and Henrik Gronberg",
year = "2020",
doi = "10.1186/s13063-020-04515-8",
language = "English",
volume = "21",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central Ltd.",
}
RIS
TY - JOUR
T1 - The ProBio trial
T2 - molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
AU - Crippa, Alessio
AU - De Laere, Bram
AU - Discacciati, Andrea
AU - Larsson, Berit
AU - Connor, Jason T.
AU - Gabriel, Erin E.
AU - Thellenberg, Camilla
AU - Janes, Elin
AU - Enblad, Gunilla
AU - Ullen, Anders
AU - Hjalm-Eriksson, Marie
AU - Oldenburg, Jan
AU - Ost, Piet
AU - Lindberg, Johan
AU - Eklund, Martin
AU - Gronberg, Henrik
PY - 2020
Y1 - 2020
KW - Clinical trial platform
KW - Genetic biomarker
KW - Prostate cancer
KW - Precision medicine
U2 - 10.1186/s13063-020-04515-8
DO - 10.1186/s13063-020-04515-8
M3 - Journal article
VL - 21
JO - Trials
JF - Trials
SN - 1745-6215
M1 - 579
ER -
